Comments to CMS Guidance on the Medicare Prescription Drug Inflation Rebate Program Due March 11, 2023 | Epstein Becker & Green
On February 9, 2023, the Centers for Medicare & Medicaid Services (“CMS”) issued a fact sheet and its initial guidance documents addressing the Medicare Prescription Drug Inflation...